ArticleNPJ digital medicine2025
A randomized controlled trial of a trauma-informed smartphone application in reducing firefighters' mental health symptoms.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many workforces are exposed to traumatic events which can precipitate the development of depression, anxiety and posttraumatic stress symptoms. This randomized controlled trial aimed to evaluate if an app-based version of the Skills for Life Adjustment and Resilience program (SOLAR-m) was superior to an active mood monitoring control app in reducing symptoms of depression and anxiety (Hospital Anxiety Depression Scale) at 8-weeks post baseline (primary) and 3-months post intervention in firefighters. Firefighters (N = 163) experiencing distress were randomized 1:1 to SOLAR-m or control. Secondary outcomes included posttraumatic stress symptoms and work-related outcomes. Longitudinal analysis on an intention-to-treat basis showed a greater decrease in depression and anxiety at 8-weeks for SOLAR-m (mean difference -2.64, 95% CI: -4.64, -0.63; p = 0.01), and each of depression, anxiety and posttraumatic stress symptoms. Only depression showed a between-group difference at 3-months. SOLAR-m was efficacious in reducing symptoms of depression, anxiety and posttraumatic stress among firefighters. (Trial registration: ANZCTRN12621001141831; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382298&isReview=true ).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.